Doctor profile · Federal record
Dr. PAYAM AGHASSI, MD
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Internal Medicine Physician · Allergy & Immunology (Internal Medicine) Physician · Critical Care Medicine (Internal Medicine) Physician · Sleep Medicine (Internal Medicine) Physician · LEOMINSTER, MA
- NPI 1093704298
- Accepts Medicare
- MIPS 89.0 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
50 MEMORIAL DRIVE, SUITE 113
LEOMINSTER, MA 014532238
(978) 466-2692
fax (978) 466-4754 - Mailing address
-
PO BOX 726
LEOMINSTER, MA 01453
Credentials & registration
- NPI registered
- October 2005 — 21 yrs on file
- Profile last updated
- April 17, 2012
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- Massachusetts #216511 · Massachusetts ##216511
- Medicaid
- MA #2121247
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093704298. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,145
Distinct HCPCS
10
Medicare allowed
$437,467
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 730 | 213 | $121 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 558 | 384 | $183 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 538 | 468 | $130 | |
99291 |
Critical care, first 30-74 minutes | 383 | 120 | $214 | |
99292 |
Critical care, each additional 30 minutes | 137 | 64 | $105 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 133 | 133 | $224 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 124 | 115 | $177 | |
95806 |
Sleep study including heart rate, breathing, airflow, and effort | 103 | 102 | $96 | |
94729 |
Test to examine how well the lungs exchange gases | 99 | 99 | $9 | |
94726 |
Test to determine lung volumes using sensors | 91 | 91 | $12 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 185. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$2,197
Transactions
91
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $680.21 | |
| GlaxoSmithKline, LLC. | 22 | $392.32 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $270.01 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $99.95 | |
| Axsome Therapeutics, Inc. | 3 | $96.58 | |
| United Therapeutics Corporation | 4 | $93.12 | |
| Regeneron Healthcare Solutions, Inc. | 5 | $87.56 | |
| Electromed, Inc. | 4 | $86.78 | |
| Actelion Pharmaceuticals US, Inc. | 2 | $55.43 | |
| Novartis Pharmaceuticals Corporation | 3 | $52.93 | |
| Inspire Medical Systems, Inc. | 1 | $49.85 | |
| HARMONY BIOSCIENCES LLC | 2 | $42.22 | |
| Mallinckrodt Hospital Products Inc. | 1 | $34.99 | |
| Grifols USA, LLC | 1 | $26.15 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21.93 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,977
Patients
606
Total drug cost
$809,332
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 418 | 165 | $14,342 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 355 | 87 | $312,821 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 216 | 56 | $165,953 |
| Fluticasone Propionate | Generic | 149 | 61 | $1,878 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 134 | 34 | $65,706 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 99 | 24 | $58,383 |
| Advair Diskus (Fluticasone Propion/Salmeterol) | Brand | 90 | 17 | $50,968 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 89 | 27 | $8,639 |
| Montelukast Sodium | Generic | 85 | 31 | $1,743 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 83 | 22 | $56,652 |